Gapping up
In reaction to strong earnings/guidance:
- NA
M&A news:
Other news:
- AMRX +22.6% (accelerates hydroxychloroquine sulfate production in response to COVID-19 outbreak)
- PCG +15% (announces new commitments that resolve Governor's concerns about plan of reorganization)
- DHR +8.7% (unit Cepheid receives Emergency Use Authorization from FDA for rapid SARS-CoV-2 Test)
- BA +4.5% (provides update on actions to navigate COVID-19 crisis; suspends dividend)
- OGI +3.2% (receives health canada license renewal and expansion for final elements of phase 5 and provides COVID-19 update) .
Analyst comments:
- LTM +0.9% (upgraded to Outperform from Mkt Perform at Raymond James)
- PEP +0.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- KO +0.5% (upgraded to Overweight from Neutral at JP Morgan)
